Stocks and Investing
Stocks and Investing
Wed, May 8, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, May 7, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Etzer Darout Maintained (BNTX) at Buy with Decreased Target to $122 on, May 7th, 2024
Etzer Darout of BMO Capital, Maintained "BioNTech SE" (BNTX) at Buy with Decreased Target from $123 to $122 on, May 7th, 2024.
Etzer has made no other calls on BNTX in the last 4 months.
There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Etzer's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $101 on, Wednesday, March 27th, 2024
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $100 on, Wednesday, February 28th, 2024
These are the ratings of the 3 analyists that currently disagree with Etzer
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $107 on, Wednesday, April 17th, 2024
- Jessica Fye of "JP Morgan" Maintained at Sell with Decreased Target to $90 on, Friday, March 22nd, 2024
- Bill Maughan of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $171 on, Thursday, March 21st, 2024
Contributing Sources